Taro to Announce Full Year Results on May 17, 2018

Earnings Call to Discuss Results to be Conducted Friday, May 18 at 8:00 am EDT

HAWTHORNE, N.Y.--()--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2018, on Thursday, May 17, 2018.

The Company will conduct an earnings call at 8:00 am EDT on Friday, May 18, 2018, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am EDT on Friday, May 18, 2018)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event     Date and time    

Telephone number / website

Earnings release     May 17, 2018 (AMC)    

www.taro.com

Earnings conference call

   

May 18, 2018

   

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

8:00 am EDT

Participant International Dial-In Number: +1 (716) 247-5800

ID: 3249428

 

 

   

 

   

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call

May 18, 2018 to

+ 1 (855) 859-2056 or +1 (404) 537-3406

 

May 31, 2018

ID: 3249428

 

 

   

 

   

Via audio webcast playback, details of which will be made available on www.taro.com

 

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Contacts

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer, 914-345-9001
VP, CFO
Mariano.Balaguer@taro.com
or
William J. Coote, 914-345-9001
AVP, Business Finance, Treasurer and Investor Relations
William.Coote@taro.com

Recent Stories

RSS feed for Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.